C H Chesnut

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.

D. Kiel, S. Silverman, H. Genant, 2000, The American journal of medicine.

Osteoporotic bone fragility. Detection by ultrasound transmission velocity.

R R Recker, R. Recker, L. Avioli, 1989, JAMA.

Fractures Attributable to Osteoporosis: Report from the National Osteoporosis Foundation

T A Einhorn, C C Johnston, S. Silverman, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Long-term calcitonin therapy in postmenopausal osteoporosis.

W. Nelp, H. Gruber, C. Chesnut, 1984, Metabolism: clinical and experimental.

Osteoblast and osteoclast cell number and cell activity in postmenopausal osteoporosis.

C. Chesnut, C H Chesnut, H. Gruber, 1986, Mineral and electrolyte metabolism.

Ability of four different techniques of measuring bone mass to diagnose vertebral fractures in postmenopausal women

R F Kilcoyne, S. Ott, C. Chesnut, 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone mineral density after resumption of menses in amenorrheic athletes.

B L Drinkwater, B. Drinkwater, S. Ott, 1986, JAMA.

Menstrual history as a determinant of current bone density in young athletes.

B L Drinkwater, B. Drinkwater, C. Chesnut, 1990, JAMA.

Tiludronate: development as an osteoporosis therapy.

C. Chesnut, C H Chesnut, 1995, Bone.

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

H K Genant, Jacques P. Brown, H. Genant, 1999, JAMA.

Bone mineral content of amenorrheic and eumenorrheic athletes.

W J Bremner, B L Drinkwater, B. Drinkwater, 1984, The New England journal of medicine.